National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH).
Clin Cancer Res
; 29(8): 1412-1422, 2023 04 14.
Article
in En
| MEDLINE
| ID: mdl-36662819
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms
/
Antineoplastic Agents
Type of study:
Clinical_trials
Limits:
Child
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Country of publication: